(Q35976273)

11 August 2017

Chemotherapeutic treatment of recurrent and/or metastatic nasopharyngeal carcinoma: a retrospective analysis of 40 cases (English)

1 reference

11 August 2017

1 reference

Gebbia V

1

1 reference

11 August 2017

Zerillo G

2

1 reference

11 August 2017

Restivo G

3

1 reference

11 August 2017

Speciale R

4

1 reference

11 August 2017

Cupido G

5

1 reference

11 August 2017

Lo Bue P

6

1 reference

11 August 2017

Ingria F

7

1 reference

11 August 2017

Gallina S

8

1 reference

11 August 2017

Spatafora G

9

1 reference

11 August 2017

Testa A

10

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 July 1993

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

68

1 reference

11 August 2017

1

1 reference

11 August 2017

191-194

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1993.312

11 August 2017

0 references

cites work

Nasopharyngeal cancer: a review of 1605 patients treated radically with cobalt 60.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968311

Importance of primary site in assessing chemotherapy response and 7-year survival data in advanced squamous-cell carcinomas of the head and neck treated with initial combination chemotherapy without cisplatin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968311

Head and neck cancer: chemotherapy concepts.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968311

Nasopharyngeal carcinoma. Brief review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968311

Chemotherapy for recurrent or metastatic carcinoma of the nasopharynx. A review of the Princess Margaret Hospital experience

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968311

High Complete Response in Advanced Nasopharyngeal Carcinoma With Bleomycin, Epirubicin, and Cisplatin Before Radiotherapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968311

Chemotherapy in head and neck cancer (I): Management of recurrent or metastatic disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968311

Cis-diamminodichloroplatinum plus a 5-day continuous infusion of 5-fluorouracil in the treatment of locally recurrent and metastatic head and neck cancer patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968311

11 July 2018

Nasopharyngeal carcinoma

1 reference

12 December 2020

High-dose folinic acid and 5-fluorouracil plus cisplatin on a weekly schedule in the treatment of advanced cancer of the head and neck

1 reference

12 December 2020

An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts

1 reference

12 December 2020

Evaluation of patients with advanced cancer using the Karnofsky performance status

1 reference

12 December 2020

Analysis of failures after definitive irradiation for epidermoid carcinoma of the nasopharynx

1 reference

12 December 2020

Nasopharyngeal cancer: study II

1 reference

12 December 2020

Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site

1 reference

12 December 2020

Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil

1 reference

12 December 2020

Patterns of failure in carcinoma of the nasopharynx: failure at distant sites

1 reference

12 December 2020

Sequential chemotherapy and radiation for nasopharyngeal cancer: absence of long-term benefit despite a high rate of tumor response to chemotherapy

1 reference

12 December 2020

Simultaneous cisplatin and 5-fluorouracil as second-line treatment of head and neck cancer

1 reference

12 December 2020

Nasopharyngeal carcinoma: the Dana-Farber Cancer Institute experience with 24 patients treated with induction chemotherapy and radiotherapy

1 reference

12 December 2020

Continuous cisplatin (24-hour) and 5-fluorouracil (120-hour) infusion in recurrent head and neck squamous cell carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1993.312

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

7686391

1 reference